Tissue inhibitors of metalloproteinases in liver fibrosis

International Journal of Biochemistry and Cell Biology

Volumn 29, Issue 1, 1997, Pages 43-54

  Iredale, J P ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Collagenase; Liver fibrosis; Matrix degradation; Tissue inhibitors of metalloproteinases (TIMPs)

Indexed keywords

METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

CELL TRANSFORMATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; REVIEW; STELLATE CELL;

ANIMALS; COLLAGENASES; EXTRACELLULAR MATRIX; GLYCOPROTEINS; HUMANS; LIVER CIRRHOSIS; METALLOENDOPEPTIDASES; PROTEASE INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASES;

ANIMALIA;

EID: 0031018997     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(96)00118-5     Document Type: Review

References (109)

1. Aimes R. T. and Quigley J. P. (1995) Matrix metalloproteinase-2 is an interstitial collagenase - inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4-and 1/4-length fragments. J. biol. Chem. 270, 5872-5876.
2. Apte S. S., Mattei M. G. and Olsen B. R. (1994) Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (Timp-3) and mapping of the Timp-3 gene to chromosome 22. Genomics 19, 86-90.
3. Arenson D. M., Friedman S. L. and Bissell D. M. (1988) Formation of extracellular matrix in normal rat liver: lipocytes as a major source of proteoglycan. Gastroenterology 95, 441-447.
4. Arthur M. J. P. (1994) Matrix degradation in the liver. In Fat-Storing Cells and Liver Fibrosis (Eds Surrenti C., Casini A., Milani S. and Pinzani M.), pp. 110-127. Kluwer Academic, Dordrecht.
5. Arthur M. J. P., Friedman S. L., Roll F. J. and Bisseil D. M. (1989) Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J. Clin. Invest. 84, 1076-1085.
6. Arthur M. J. P., Stanley A., Iredale J. P., Rafferty J. A., Hembry R. M. and Friedman S. L. (1992) Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes: analysis of gene expression, protein synthesis and proteinase activity. Biochem. J. 287, 701-707.
7. Bachern M. G., Meyer D., Melchior R., Sell K.-M. and Gressner A. M. (1992) Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast-like cells. J. Clin. Invest. 89, 19-27.
8. Barsky S. H. and Gopal Krishna R. (1988) High metalloproteinase inhibitor content of human cirrhosis and its possible conference of metastasis resistance. J. Natl Cancer Inst. 80, 102-108.
9. Benyon R. C., Iredale J. P., Goddard S., Winwood P. J. and Arthur M. J. P. (1996) Increased expression of tissue inhibitor of metalloproteinases-1 and -2 relative to interstitial collagenase in fibrotic human liver. Gastroenterology 110, 821-831.
10. Boone T. C., Johnson M. J., De Clerck Y., A. and Langley K. E. (1990) cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc. Natl Acad. Sci. U.S.A. 87, 2800-2804.
11. Carome M. A., Striker L. J., Peten E. P., Moore J., Yang C. W., Stetlerstevenson W. G. and Striker G. E. (1993) Human glomeruli express TIMP-1 messenger RNA and TIMP-2 protein and messenger RNA. Am. J. Physiol. 264, F923-F929.
12. Cawston T. E., Murphy G., Mercer E., Galloway W. A., Hazleman B. L. and Reynolds J. J. (1983) The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem. J. 211, 313-318.
13. 4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinuisoidal endothelial cells. Hepatology 21, 1429-1437.
14. De Clerck Y. A., Yean T.-S., Lu H. S., Ting J. and Langley K. E. (1991) Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J. biol. Chem. 266, 3893-3899.
15. De Clerck Y. A., Darville M. I., Eeckhout Y. and Rousseau G. G. (1994) Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 139, 2, 185-191.
16. Denhardt D. T., Feng B., Edwards D. R., Cocuzzi E. T. and Malyankar U. M. (1993) Tissue inhibitor of metalloproteinases (TIMP, aka EPA) - structure, control of expression and biological functions. Pharmacol. Ther. 59, 329-341.
17. Docherty A. J. P., Lyons A., Smith B. J., Wright E. M., Stephens P. E., Harris T. J. R., Murphy G. and Reynolds J. J. (1985) Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318, 66-69.
18. Edwards D. R., Murphy G., Reynolds J. J., Whitham S. E., Docherty A. J., Angel P. and Heath J. K. (1987) Transforming growth factor-beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J1 6, 1899-1904.
19. Edwards D. R., Rocheleau H., Sharma R. R., Wills A. J., Cowie A., Hassell J. A. and Heath J. K. (1992) Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim. Biophys. Acta 1171, 41-55.
20. Emonard H., Guillouzo A., Lapiere C. M. and Grimaud J. A. (1990) Human liver fibroblast capacity for synthesizing interstitial collagenase in vitro. Cell. Mol. Biol. 36, 461-467.
21. Freije J. M. P., Diezitza I., Balbin M., Sanchez L. M., Blasco R., Tolivia J. and Lopezotin C. (1994) Molecular cloning and expression of coliagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. biol. Chem. 269, 16766-16773.
22. Fridman R., Fuerst T. R., Bird R. E., Hoyhtya M., Oelkuct M., Kraus S., Komarek D., Liotta L. A., Berman M. L. and Stetlerstevenson W. G. (1992) Domain structure of human 72 kDa gelatinase type-IV collagenase characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J. biol. Chem. 267, 15398-15405.
23. Friedman S. L. (1993) The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N. Engl. J. Med. 328, 1828-1835.
24. Friedman S. L. and Arthur M. J. P. (1989) Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet derived growth factor receptors. J. Clin. Invest. 84, 1780-1785.
25. Friedman S. L., Roll F. J., Boyles J. and Bissell D. M. (1985) Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc. Natl Acad. Sci. U.S.A. 82, 8681-8685.
26. Friedman S. L., Roll F. J., Boyles J., Arenson D. M. and Bissell D. M. (1989) Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J. biol. Chem. 264, 10756-10762.
27. Friedman S. L., Yamasaki G. and Wong L. (1994) Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. J. biol. Chem. 269, 10551-10558.
28. Fukuda Y., Imoto M. and Koyama Y. et al., (1991) Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers. Gastroenterol. Jpn 26, 37-41.
29. Goldberg G. I., Wilhelm S. M., Kronberger A., Bauer E. A., Grant G. A. and Eisen A. Z. (1986) Human fibroblast collagenase. J. biol. Chem. 261, 6600-6605.
30. Goldberg G. I., Strongm A., Collier I. E., Genrich L. T. and Marmer B. L. (1992) Interaction of 92-kDa type-IV collagenase with the tissue inhibitor of metalloproteinases prevents dimenzation, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. biol. Chem. 267, 4583-4591.
31. Gressner A. M., Lahme B., Diehl A. and Brenzel A. (1992) Hepatocytes greatly enhance the mitogenic effect of insulin-like growth factor (IGF)-1 and IGF-2 on cultured perisinusoidal lipocytes via secretion of IGF-binding protein-1: multiple potential ways of paracrine regulation of lipocyte activation. Hepatology 16, 183A.
32. Hendriks H. F. J., Brouwer A. and Knook D. L. (1987) The role of fat-storing (stellate) cells in retinoid metabolism. Hepatology (Baltimore) 7, 1368-1371.
33. Herbst H., Heinrichs O., Schuppan D., Milani S. and Stein H. (1991) Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver. Virchows Arch. B Cell. Pathol. 60, 295-300.
34. Howard E. W. and Banda M. J. (1991) Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. J. biol. Chem. 266, 17972-17977.
35. Howard E. W., Bullen E. C. and Banda M. J. (1991) Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J. biol. Chem. 266, 13064-13069.
36. Hunt J. (1992) Long-term follow-up of patients with hepatitis B treated with interferon. Interferons and Cytokines 20, 6-9.
37. Iredale J. P. (1996a) Matrix turnover in fibrogenesis. Hepatogastroenterohgy 43, 56-71.
38. Iredale J. P. and Arthur M. J. P. (1994) Hepatocyte-matrix interactions. Gut 35, 729-732.
39. Iredale J. P., Murphy G., Hembry R. M., Friedman S. L. and Arthur M. J. P. (1992) Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1 (TIMP-1): implications for regulation of matrix degradation in liver. J. Clin. Invest. 90, 282-287.
40. Iredale J. P., Winwood P. J., Kawser C. A. and Arthur M. J. P. (1993) Lipocyte proliferation in the C. parvum model of macrophage-induced liver injury is associated with expression of 72 kDa type IV collagenase/gelatinase. In Cells of the Hepatic Sinusoid, Vol 4 (Eds Knook D. L. and Wisse E.), pp. 105-108. Kupffer Cell Foundation, Leiden.
41. Iredale J. P., Goddard S., Murphy G., Benyon R. C. and Arthur M. J. P. (1995) Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin. Sci. 89, 75-81.
42. Iredale J. P., Ferris W. F., Goddard S., Alcolado R., Winwood P. J., Murphy G. and Arthur M. J. P. (1996b) TIMP-1 expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 24(1), 176-184.
43. Kordula T., Guttgemann I. and Rosejohn S. et al., (1992) Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2) - up-regulation by interleukin-6 and transforming growth factor-beta 1. FEBS Lett. 313, 143-147.
44. Leo M. A., Mak K. M., Savolainen E. R. and Lieber C. S. (1985) Isolation and culture of myofibroblasts from rat liver (42193). Proc. Soc. Exp. Biol. Med. 180, 382-391.
45. Leyland H., Benyon R. C., Vyas S. K. and Arthur M. J. P. (1994) The plasminogen activating system in hepatic lipocytes and its modulation by retinoic acid. Hepatology 20, 293A.
46. Li J. J., Kim C. I., Leo M. A., Mak K. M., Rojkind M. and Lieber C. S. (1992) Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by-stimulating collagenase activity in cultured lipocytes. Hepatology 15, 373-381.
47. Mäher J. J. (1989) Fat-storing cells and myofibroblasts: one cell or two? Hepatology 9, 903-904.
48. Mäher J. J. and McGuire R. F. (1990) Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J. Clin. Invest. 86, 1641-1648.
49. Maher J. J., Friedman S. L., Roll F. J. and Bissell D. M. (1988) Immunolocalization of laminin in normal rat liver and biosynthesis of laminin by hepatic lipocytes in primary culture. Gastroenterology 94, 1053-1062.
50. Mak K. M. and Lieber C. S. (1988) Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology (Baltimore) 8, 1027-1033.
51. Mak K. M., Leo A. M. and Lieber C. S. (1984) Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology 87, 188-200.
52. Marshall B. C., Santana A., Xu Q. P., Petersen M. J., Campbell E. J., Hoidal J. R. and Welgus H. G. (1993) Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells cellular differentiation influences expression. J. Clin. Invest. 91, 1792-1799.
53. Maruyama K., Feinman L., Okazaki I. and Lieber C. S. (1981) Direct measurement of neutral collagenase activity in homogenates from baboon and human liver. Biochim. Biophys. Acta 658, 121-131.
54. Maruyama K., Feinman L., Fainsilber Z., Nakano M., Okazaki I. and Lieber C. S. (1982) Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis. Life Sci. 30, 1379-1384.
55. Matrisian L. M. (1990) Metalloproteinases and their inhibitors in matrix remodelling. Trend Genet. 6, 121-125.
56. Matrisian L. M. (1992) The matrix-degrading metalloproteinases, Bioessays 14, 455-463.
57. Matsuoka M. and Tsukamoto H. (1990) Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 11, 599-605.
58. McGee J. O. and Patrick R. S. (1972) The role of perisinusoidal cells in hepatic fibrogenesis. An electron microscopic study of acute carbon tetrachloride liver injury. Lab. Invest. 26, 429-440.
59. Milani S., Herbst H., Schuppan D., Hahn E. G. and Stein H. (1989) In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. Hepatology 10, 84-92.
60. Milani S., Herbst H., Schuppan D., Kim K. Y., Riecken E. O. and Stein H. (1990a) Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. Gastroenterology 98, 175-184.
61. Milani S., Herbst H., Schuppan D., Surrenti C., Riecken E. O. and Stein H. (1990b) Cellular localization of type I, III and IV procollagen gene transcripts in normal and fibrotic human liver. Am. J. Pathol. 137, 59-70.
62. Milani S., Pinzani M., Casini A., Schuppan D., Herbst H., Grappone C., Pellegnni G., Gentilini A. and Surrenti C. (1992) Interstitial collagenase gene is differentially expressed in human liver and cultured fat-storing cells. Hepatology, 16, 186A.
63. Minato Y., Hasumura Y. and Takeuchi J. (1983) The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease. Hepatology 3, 559-566.
64. Montano M., Ramos C., Gonzalez G., Vadillo F., Pardo A. and Selman M. (1989) Lung collagenase inhibitors and spontaneous and latent collagenase activity in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Chest 96, 1115-1119.
65. Murawaki Y., Yamamoto H., Kawasaki H. and Shima H. (1993) Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma. Clin. Chim. Acta 218, 47-58.
66. Murawaki Y., Kawasaki H. and Burkhardt H. (1994) Serum collagenase activity in chronic liver diseases. Pathol. Res. Pract. 190, 929-933.
67. Murphy G. and Docherty A. J. P. (1992) The matrix metalloproteinases and their inhibitors. Am. J. Resp. Cell Molec. Biol. 7, 120-125.
68. Murphy G. and Hembry R. M. (1992) Proteinases in rheumatoid arthritis. J. Rheumatol. 19, 61-64.
69. Murphy G., Cawston T. E. and Reynolds J. J. (1981) An inhibitor of collagenase from human amniotic fluid. Biochem. J. 195, 167-170.
70. Murphy G., Cockett M. I., Stephens P. E.. Smith B. J. and Docherty A. J. (1987) Stromelysin is an activator of procollagenase. Biochem. J. 248, 265-268.
71. Murphy G., Koklitis P. and Carne A. F. (1989) Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor. Biochem. J. 261, 1031-1034.
72. Murphy G., Hembry R. M., Hughes C. E., Fosang A. J. and Hardingham T. E. (1990) Role and regulation of metalloproteinases in connective tissue turnover. Biochem. Soc. Trans. 18, 812-815.
73. Murphy G., Docherty A. J. P., Hembry R. M. and Reynolds J. J. (1991) Metalloproteinases and tissue damage. Br. J. Rheumatol. 30, Suppl. 1, 25-31.
74. Murphy G., Atkinson S., Ward R., Gavrilovic J. and Reynolds J. J. (1992) The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann. N. Y. Acad. Sci. 667, 1-12.
75. Muzzillo D. A., Imoto M., Fukuda Y., Koyama Y., Saga S., Nagai Y. and Hayakawa T. (1993) Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases. J. Gastroenterol. Hepatol. 8, 437-441.
76. Nagase H., Jackson R. C., Brinckerhoff C. E., Vater C. A. and Harris E. D. J. (1981) A precursor form of latent collagenase produced in a cell free system with mRNA from rabbit synovial cells. J. biol. Chem. 256, 11951-11954.
77. Nagase H., BrinckerhofF C. E., Vater C. A. and Harris E. D. J. (1983) Biosynthesis and secretion of procollagenase by rabbit synovial fibroblasts. Biochem. J. 214, 281-288.
78. Nakamura T., Ebihara I. and Osada S. et al., (1993) Gene expression of metalloproteinases and their inhibitor in renal tissue of New Zealand black/white F(1)-mice. Clin. Sci. 85, 295-301.
79. Nakatsukasa H., Evarts R. P., Hsia C. C. and Thorgeirsson S. S. (1990) Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosts of rat liver. Lab. Invest. 63, 171-180.
80. Okazaki I. and Maruyama K. (1974) Collagenase activity in experimental hepatic fibrosis. Nature 252, 49-50.
81. Overall C. M., Wrana J. L. and Sudek J. (1989) Independent regulation of collagenase, 72 kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J. biol. Chem. 264, 1860-1869.
82. Overall C. M., Wrana J. L, and Sodek J. (1991) Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. J. biol. Chem. 266, 14064-14071.
83. Pardo A., Selman M., Ramirez R., Ramos C., Montano M., Stricklin G. and Raghu G. (1992) Production of collagenase and tissue inhibitor of metalloproteinases by fibroblasts derived from normal and fibrotic human lungs. Chest, 102, 1085-1089.
84. Pavloff N., Staskus P. W., Kishnani N. S. and Hawkes S. P. (1992) A new inhibitor of metalloproteinases from chicken - ChIMP-3 - a 3rd member of the TIMP family. J. biol. Chem. 267, 17321-17326.
85. Perez-Tamayo R., Montfort I. and Gonzalez E. (1987) Collagenolytic activity in experimental cirrhosis of the liver. Exp. Mol. Pathol. 47, 300-308.
86. Pinzani M., Gesukado L., Sabbah G. M. and Abboud H. E. (1989) Effects of platelet derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat storing cells. J. Clin. Invest. 84, 1786-1793.
87. Pinzani M., Abboud H. E. and Aron D. C. (1990) Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: regulatory role of platelet-derived growth factor. Endocrinology 127, 2343-2349.
88. Ramadori G., Rieder H., Knittel T., Dienes H. P. and Meyer zum Buschenfelde K.-H. (1987) Fat storing cells (FSC) of rat liver synthesize and secrete fibronectin. J. Hepatol. 4, 190-197.
89. Roeb E., Graeve L., Hoffmann R., Decker K., Edwards D. R. and Heinrich P. C. (1993) Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology 18, 1437-1442.
90. Roeb E., Rosejohn S., Erren A., Edwards D. R., Matern S., Graeve L. and Heinrich P. C. (1995) Tissue inhibitor of metalloproteinases-2 (TIMP-2) in rat liver cells is increased by lipopolysaccharide and prostaglandin E(2). FEBS Lett. 357, 33-36.
91. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E. and Seiki M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65.
92. Schafer S., Zerbe O. and Gressner A. M. (1987) The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology (Baltimore) 7, 680-687.
93. Schorpp M., Mattei M.-G., Herr I., Gack S., Schaper J. and Angel P. (1995) Structural organization and chromosomal localization of the mouse collagenase type I gene. Biochem. J. 308, 211-217.
94. 4-or vitamin A-treated rats. Dig. Dis. Sci. 32, 1281-1289.
95. Stetler-Stevenson W. G., Brown P. D., Onisto M., Levy A. T. and Liotta L. A. (1990) Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. biol. Chem. 265, 13933-13938.
96. Takahara T., Kojima T. and Miyabayashi C. et al., (1988) Collagen production in fat-storing cells after carbon tetrachloride intoxication in the rat. Immunoelectron microscopic observation of type I, type III collagens, and prolyl hydroxylase. Lab. Invest. 59, 509-521.
97. Takahashi S. and Simpser E. (1981) Granuloma collagenase and EDTA-sensitive neutral protease production in hepatic murine schistosomiasis. Hepatology 1, 211-220.
98. Takahashi S. and Koda K. (1984) Radioimmunoassay of soluble and insoluble collagenases in fibrotic liver. Biochem. J. 220, 157-164.
99. Takahashi S., Dunn M. A. and Seifter S. (1980) Liver collagenase in murine schistosomiasis. Gastroenterology 78, 1425-1431.
100. Takino T., Sato H., Shinagawa A. and Seiki M. (1995) Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J. biol. Chem. 270, 23013-23020.
101. Truden J. L. and Boros D. L. (1988) Detection of alpha-2-macroglobulin, alpha-1-protease inhibitor, and neutral protease-antiprotease complexes within liver granulomas of Schistosoma mansoni-infected mice. Am. J. Pathol. 130, 281-288.
102. Vyas S. K., Leyland H., Gentry J. and Arthur M. J. P. (1995) Transin (stromelysin) is expressed in early rat lipocyte primary culture. Gastroenterology 109, 889-898.
103. Wahl S. M., Allen J. B., Weeks B. S., Wong H. L. and Klotman P. E. (1993) Transforming growth factor-beta enhances integrin expression and type-IV collagenase secretion in human monocytes. Proc. Natl Acad. Sci. U.S.A. 90, 4577-4581.
104. Wake H. (1980) Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs. Int. Rev. Cytol. 66, 303-353.
105. ard R. V., Atkinson S. J., Slocombe P. M., Docherty A. J. P., Reynolds J. J. and Murphy G. (1991) Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim. Biophys. Acta 1079, 242-246.
106. Weber B. H. F., Vogt G., Pruett R. C., Stohr H. and Felbor U. (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat. Genet. 8, 352-356.
107. Wick M., Haronen R., Mumberg D., Burger C., Olsen B. R., Budarf M. L., Apte S. S. and Muller R. (1995) Structure of the human TIMP-3 gene and its cell cycle-regulated promoter. Biochem. J. 311, 549-554.
108. Will H. and Hinzmann B. (1995) cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231, 602-608.
109. Winwood P. J., Schuppan D., Iredale J. P., Kawser C. A., Docherty A. J. P. and Arthur M. J. P. (1995) Kupffer cell-derived 95 kDa type IV collagenase/gelatinase B: characterisation and expression in cultured cells. Hepatology 22, 304-315.